Word

VECTURA

Status

Dead

Status Code

710

Status Date

Friday, October 20, 2023

Serial Number

86698312

Registration Number

5174039

Registration Date

Tuesday, April 4, 2017

Mark Type

4000

Filing Date

Monday, July 20, 2015

Published for Opposition

Tuesday, January 17, 2017

Cancellation Date

Friday, October 20, 2023

Trademark Owner History

Vectura Limited - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field

10 Surgical, medical, and veterinary apparatus, instruments and parts and fittings therefor, namely, drug delivery devices and parts and fittings therefor, namely, drug delivery systems; inhalers for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapy, namely, respiration therapy, and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; dispensing devices for the metering and dispensing of orally ingestible drugs for medical or therapeutic purposes and parts and fittings therefor, namely, medical apparatus and units for dosage and measuring, namely, drug delivery devices and systems; aerosol dispensers for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field

42 Scientific research and technological services, namely, research, design, analysis, and testing, in the field of pharmaceuticals and drug delivery systems, and drug delivery systems and devices; Scientific research and technological services, namely, research in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services; preparation and formulation of pharmaceuticals, namely, consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations

Trademark Events

Oct 20, 2023

Cancelled Sec. 8 (6-Yr)

Apr 4, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Apr 4, 2017

Registered-Principal Register

Jan 17, 2017

Official Gazette Publication Confirmation E-Mailed

Jan 17, 2017

Published For Opposition

Dec 28, 2016

Notification Of Notice Of Publication E-Mailed

Dec 12, 2016

Law Office Publication Review Completed

Nov 28, 2016

Approved For Pub - Principal Register

Nov 17, 2016

Teas/Email Correspondence Entered

Nov 17, 2016

Correspondence Received In Law Office

Nov 17, 2016

Teas Response To Office Action Received

May 25, 2016

Notification Of Non-Final Action E-Mailed

May 25, 2016

Non-Final Action E-Mailed

May 25, 2016

Non-Final Action Written

May 4, 2016

Teas/Email Correspondence Entered

May 4, 2016

Correspondence Received In Law Office

May 2, 2016

Teas Response To Office Action Received

Nov 5, 2015

Notification Of Non-Final Action E-Mailed

Nov 5, 2015

Non-Final Action E-Mailed

Nov 5, 2015

Non-Final Action Written

Oct 29, 2015

Assigned To Examiner

Oct 19, 2015

Preliminary/Voluntary Amendment - Entered

Oct 9, 2015

Assigned To Lie

Sep 21, 2015

Teas Voluntary Amendment Received

Jul 24, 2015

New Application Office Supplied Data Entered

Jul 23, 2015

New Application Entered